The Patent Finder

Terms ending in 2027

Intervet Inc.

Every in-force patent on Intervet Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,197,827Protein from Photobacterium Damselae and Use Thereof
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 7,879,809Fish Production
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 8,034,845Compositions and Method for Treating Infection in Cattle and Swine
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 8,084,445Pharmaceutical Formulation
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 8,137,678Canine Lyme Disease Vaccine
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 7,718,772Canine Thymic Stromal Lymphopoietin Protein and Uses Thereof
In force
 · High confidence
Intervet Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited